相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database
Anjali Gupta et al.
SCIENTIFIC REPORTS (2023)
Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups
Derian B. Taylor et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States
Joseph C. Ahn et al.
HEPATOLOGY (2022)
Impact of Race and Insurance Status on Primary Treatment for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Andy M. Habib et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)
Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review
Yue Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US
Theresa Ermer et al.
JAMA NETWORK OPEN (2022)
A Policy Prescription for Reducing Health Disparities-Achieving Pharmacoequity
Utibe R. Essien et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-Analysis
Andrea Botticelli et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
Hirofumi Shibata et al.
FRONTIERS IN ONCOLOGY (2021)
Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study?
Sabine Stordeur et al.
ORAL ONCOLOGY (2020)
Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States
Matthew E. Gaubatz et al.
ORAL ONCOLOGY (2019)
Immunotherapy for head and neck cancer: Recent advances and future directions
John D. Cramer et al.
ORAL ONCOLOGY (2019)
Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States
Vivek Verma et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Immune Checkpoint Inhibition in Head and Neck Cancer
Martin David Forster et al.
FRONTIERS IN ONCOLOGY (2018)
Immune Checkpoint Inhibition in Cancers that Affect the Head and Neck
Janaki Parameswaran et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States
Nosayaba Osazuwa-Peters et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
The promise of immunotherapy in head and neck squamous cell carcinoma
P. Economopoulou et al.
ANNALS OF ONCOLOGY (2016)
Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience
Nerina Denaro et al.
CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY (2016)
Untitled
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
HISTORY OF MEDICINE Donabedian's Lasting Framework for Health Care Quality
John Z. Ayanian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid
Jed J Jacobson et al.
Head and Neck Optical Diagnostics Society (2012)
Asian Americans' reports of their health care experiences - Results of a national survey
Q Ngo-Metzger et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2004)
Importance of comorbidity in head and neck cancer
JF Piccirillo
LARYNGOSCOPE (2000)